Wholesale drug acquisition and distribution stakeholders say that even by November, the industry won’t be ready to comply with the Drug Supply Chain Security Act’s (DSCSA) updated security requirements.

Comments from the industry were filed in response to the FDA’s electronic supply chain tracking proposal, which requires manufacturers, distributors, repackagers and dispensers to bring their systems into compliance with the enhanced drug distribution security requirements by Nov. 27.

But the deadline is just too big an ask, said the National Community Pharmacists Association (NCPA). “NCPA has serious concerns that the supply chain stakeholders upstream of pharmacies do not have the systems and processes in place to provide the data required to meet the November 27, 2024 enforcement deadline for DSCSA’s interoperability provisions,” the group wrote.

To read the whole story, click here to subscribe.

Related Topics